ARCHIVES

IOM Review Of Duke Genomics Trials To Focus On Validation, Scientific Criteria

This article is from The Cancer Letter archive.

Vol. 36 No. 38 | October 22, 2010

Download PDF Visit The Full Archive

Related Articles

Levamisole/5-FU Could Save $226 Mil. If Fully Adopted, NCI Economist Says

April 20, 1990

Bunn Says ASCO Is “Strong, Diverse, Respected, Growing”

June 6, 2003

In Brief: Search Narrows ACS Head; Selections For Breast Cancer Commission Still At HHS

March 27, 1992

In Brief: GAO Reopens Clinical Center Controversy On Patient Care Payment; NIH Still Resists

January 6, 1978

ACS Supports NCI’s Bypass Budget In Resolution

March 20, 1992

“Perhaps the most troubling finding was a broad dissatisfaction with the general ethos within the intramural community.”

July 14, 1995